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Abstract
Objective: The diagnosis of tuberculosis (TB) ascites is problematic. Delay in the diagnosis and treatment of TB ascites are considered 
to be major factors that contribute to the high mortality of TB. This study identifies specific protein markers in ascitic fluid which will 
be useful in diagnosis of TB ascites.
Methods: We used Two-Dimensional Electrophoresis, liquid chromatography-mass spectrometry/mass spectrometry, immunoblot 
analysis and Enzyme Linked Immunosorbent assay (ELISA) as a comprehensive quantitative proteomic screening system for the diag-
nosis of TB ascites.
Results: The screen identified several antigens of interest: a 30-kilodalton (kDa) protein that demonstrated significant homology to the 
antigen 85B and 85C (Ag 85) complex; a 65-kDa protein that corresponded to Mycobacterium tuberculosis (MTB) heat shock protein 
65 (65-kDa HSP), Rv0440; a 14-kDa protein and 71-kDa protein that exhibits an amino acid sequence identical to that of MTB heat 
shock protein 14 (14-kDa HSP), GroES; and MTB heat shock protein 71 (71-kDa HSP), Rv0350 respectively. ELISA confirmed that 
TB ascites patients were consistently positive for these antigens at higher rates than non-TB ascites patients.
Conclusion: The 65-kDa HSP, 71-kDa HSP, 14-kDa HSP and Ag 85 complex proteins may serve as very useful diagnostic markers for 
TB ascites.
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Background
Tuberculosis  (TB)  is  a  serious  infectious  disease. 
India has far more TB cases than any other coun-
try, which is a significant problem on its own. Along 
with  the  increased  incidence  of  TB,  however,  the 
incidence of extra-pulmonary TB [EPTB] has also 
recently increased.1,2 TB ascites is one of the clini-
cal signs of abdominal TB. The clinical presentation 
of TB ascites is problematic, since it is non-specific 
and can mimic the symptoms of many other infec-
tious diseases. As a result, diagnosis is often delayed.3 
These delays in the diagnosis and treatment of TB 
ascites are considered to be major factors that con-
tribute to the high   mortality of TB.4 In most cases, 
diagnosis relies on clinical observations, imaging of 
the  infected  area  and  detection  of  Mycobacterium 
tuberculosis (MTB) in ascitic fluid by either acid-fast 
bacillus (AFB) staining or culturing. The   sensitivity 
of  the    Ziehl-Neelsen  staining  test  for  direct  AFB 
detection is quite low, and, thus, AFB culture takes a 
very long time to complete.5
Over the past few decades, analyses of TB bio-
markers  have  attracted  attention  with  respect  to  a 
variety  of  extra-pulmonary  disorders.6,7  With  the 
increased interest in and improved technical capabili-
ties of clinical proteomics, comparative investigations 
with  respect  to  differential  protein  expression  has 
become more   common than ever before for the diag-
nostic and prognostic assessment of disease states.8 
In  the  present  study,  we  used  Two-  Dimensional 
  Polyacrylamide Gel Electrophoresis (2 DPGE),   liquid 
  chromatography-mass spectrometry/mass spectrometry 
(LC-MS/MS) and immunoblot analysis in the pres-
ent study as a comprehensive quantitative proteomic 
screening system for the diagnosis of TB ascites. The 
identification of new biomarkers will be useful for 
the development of sensitive and specific tests for 
the prediction and/or early diagnosis of TB ascites in 
patients.
Material and Methods
Patients and samples
We  prospectively  selected  ascitic  fluid  samples 
from  20  patients  (13  male,  7  female),  ranging  in 
age from 6 to 72 years of age, who were suspected 
to  have  TB  ascites  based  upon  clinical  symptoms 
and/or  operative  findings  from  the  inpatient  and 
outpatient services at the Central India Institute of 
  Medical   Sciences in, Nagpur. In addition, 21 control 
  individuals were selected from among patients who 
were admitted to the hospital for acute or chronic 
defined, non-TB ascites diseases, including inflam-
matory bowel disease, various infectious disorders, 
malignancy,  gastrointestinal  symptoms,  abdominal 
tenderness accompanied by non-specific fever, pneu-
monia, bronchitis, lung cancer and lung infection. All 
subjects were negative for HIV and have received 
BCG vaccination. For the collection of ascitic fluid, 
the patient was allowed to lay on his/her back with 
head at 45°–90° elevation. The area where the needle 
was to be inserted was cleaned with iodine or similar 
solution and drapped. The anesthetic was adminis-
tered to numb the area. The paracentesis needle was 
carefully inserted into the abdomen. About 1000 to 
1500 ml of fluid was removed. For diagnosis 50 ml of 
the fluid was sent to the laboratory for the analysis of 
different parameters. Samples were obtained from all 
patients before the initiation of anti-Koch treatment 
(AKT) and were stored at −20 °C until they were 
ready for experimental analysis. Patient consent was 
obtained for all samples that were collected from all 
study groups for use in this study.
The  diagnosis  of TB  ascites  was  accomplished 
through  a  combination  of  several  methodologies. 
First, a sputum microscopic examination was per-
formed of two serial sputum samples that had been 
stained with Ziehl-Neelsen Stain, according to the 
guidelines of India’s Revised National Tuberculosis 
Control Programme. Out of the twenty TB ascites 
patients, however only one was AFB-positive based 
upon the initial results for the Ziehl-Neelsen Stained 
sputum  samples.  In  the  absence  a  positive  result 
with  the  Ziehl-Neelsen  test,  tissue  biopsies  were 
taken. TB infection was diagnosed by the presence 
of  a    typical  granuloma  formation,  which  is  com-
posed  of    epithelioid  histiocytes  and  mononuclear 
  inflammatory cells, in the absence of other diagnoses. 
If both tests were negative, the patients were diag-
nosed by clinical symptoms. A clinical   diagnosis of 
TB ascites was confirmed after a successful empiric 
therapeutic trial.
Cases  were  followed  at  regular  interval  over  a 
period of nine months. Improvement in all subjects 
was  judged  based  upon  clinical  criteria,    including Tuberculous ascites diagnosis
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improvements  in  abdominal  pain,  cough,  fever, 
  appetite  and,  weight  gain,  as  well  as  radiographic 
evidence. The  Ethical  Committee  of  Central  India 
Institute of Medical Sciences, Nagpur, approved the 
study. All analyses were performed double blinded.
One- and two-dimensional PAge
For the first dimension, 125 µl (150 ug protein) of 
each sample from the TB ascites and non- TB ascites 
groups was applied to a Bio-Rad IPG strip (pH 3-10, 
7 cm) and then it was subjected to isoelectric focus-
ing (IEF). Briefly, the IPG strips were rehydrated 
overnight and IEF was then carried out at 20 °C in 
a Protean IEF unit (Bio-Rad, USA). Prior to second 
dimension electrophoresis, the IPG gel strips were 
immersed in equilibration solution for 15 min. The 
second dimension separations were carried out at 
10 °C using SDS slab gels (10%) without   stacking 
gels and a mini-protean tetra cell electrophoresis 
system (Bio-Rad). The IPG strips were embedded 
on the top of the gels with 0.5% agarose, and elec-
trophoresis was performed at 30 mA/gel for 1 h. The 
gels were fixed with a methanol:acetic acid:water 
(5:1:5)   solution, stained with Coomassie brilliant 
blue Stain and destained in a solution of 10% meth-
anol and 7% acetic acid. Gel images were taken 
using the gel documentation   system (Bio-Rad) and 
were imported into the PD Quest (Bio-Rad) 2D gel 
analysis software package. For detection of spots a 
master gel image was   created by combining all of 
the spots that were present in both the TB ascites 
and non-TB ascites groups and was used to match 
each spot.
Antibodies
Antibodies against the purified MTB 85B and 85C 
(Ag85) complex, CS-90, the MTB heat shock   protein 
65, (65-kDa HSP), Rv0440, and, the MTB heat shock 
protein 71, (71-kDa HSP), Rv0350, were obtained from 
Colorado State University through the TB Research 
Materials  and  Vaccine    Testing  Contract  (NO1-AI-
75320).  A  polyclonal  antibody  (PAb)  against  the 
MTB heat shock protein 14, (14-kDa HSP), GroES, 
was raised in rabbits [1:4000]   (Bangalore Genei, Ban-
galore), and the corresponding IgG was purified from 
whole serum using   column chromatography.
Immunoblot analysis
After two-dimensional electrophoresis, the gel was 
transferred to a nitrocellulose membrane by electrob-
lotting at 100 V for 3 h. The membrane was incubated 
with the primary antibodies (PAbs) of interest [14-kDa 
HSP (1:4000); Ag 85 complex (1:2000); 65-kDa HSP; 
71-kDa HSP] for 2 h at room   temperature, followed 
by incubation with the secondary antibody, which was 
goat anti-rabbit IgG conjugated to horseradish peroxi-
dase (HRP). Antibody reactivity was visualized by the 
detection of HRP activity with tetramethylbenzidine- 
hydrogen peroxide (TMB/H2O2) as a substrate.
Indirect enzyme linked immunosorbent 
assay (eLIsA) protocol
Indirect ELISA was performed as previously described 
by Kashyap et al.9 Briefly, 100 µl (1:400) ascitic fluid 
samples from TB ascites patients and the   individuals 
in the non-TB ascites group were added to the micro-
titer  wells  and  blocked  with  0.5%  bovine  serum 
albumin (BSA) in phosphate buffered saline (PBS). 
After washing with PBS, the respective antibodies 
(Ag 85 complex at 1:5000, 14-kDa HSP at 1:2000, 
65-kDa HSP at 1:5000 and 71-kDa HSP at 1:3000) 
were added and the plates were incubated at 37 °C 
for 60 min. The wells were washed, then secondary 
antibody  (goat  anti-rabbit  IgG-HRP,  1:10000)  was 
added and the samples were incubated for 60 min at 
37 °C. After another wash with PBS, 100 µl of TMB/
H2O2 substrate was added to the wells and incubated 
at room temperature for about 10 min. The reaction 
was then stopped with 100 µl of 2.5 N H2SO4. The 
absorbance of each well was read at 450 nm. Each 
sample was tested in triplicate.
Lc-Ms analysis
An excised protein band was sent to Pro-Tech,    Australia 
for LC-MS/MS analysis. Pro-Tech,   Australia charac-
terized this protein using the following protocol: (1) 
each gel piece was destained and washed prior to in-
gel digestion, (2) protein bands was excised, digested 
and treated with trypsin after reduction and (3) alky-
lation agents were added prior to the analysis on the 
LC-MS/MS.
In-gel  digestion  was  carried  out  in  50  mM 
NH4HCO4 buffer, pH 8.5 at 37 °C for approximately 
4 hours. An equal volume of the digestion buffer was Kashyap et al
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added, depending on the volume of the gel piece, 
and usually ranged from 20 to 50 µl. The amount 
of   proteolytic enzyme (Promega trypsin, modified, 
sequencing grade) that was used depended on both 
the size of the gel piece and the estimated amount 
of protein within the gel band. Typically, 200 ng to 
1  µg  trypsin  was  used  per  gel  band.  Acetonitrile 
(ACN), in a volume equal to 3–5 times the volume of 
the   digestion buffer, was then added to the digestion 
mix to extract the peptides. The samples, were then 
  centrifuged at high speed for five minutes. The super-
natant was transferred to a clean microfuge tube with 
a  gel-  loading  pipette  tip  and  dried  in  a  SpeedVac 
on medium heat. For the reduction step, alkylation 
agents were added prior to analysis with LC-MS/MS. 
The  dried  sample  was  dissolved  in  0.5%  acetic 
acid  (HOAC)  for  LC-MS/MS  analysis. A  Finnigan 
  (ThermoFinnigan, San Jose, CA) LCQ ion trap MS 
in-line coupled with a high pressure liquid chroma-
tography (HPLC) system was used for LC-MS/MS. 
A 75 µm (ID) × 10 cm length, 3 µm packing C18 
capillary column, which was packed in-house, was 
connected to a specially designed nanoSpray device, 
which is capable of   delivering a stable electrospray 
at  flow  rates  of  100  nl/min  to  1500  nl/min.  The 
mobile phases included Solvent A (2% ACN, 97.5% 
H2O, 0.1% formic acid) and Solvent B (90% ACN, 
9.5% H2O, 0.1% formic acid). For this analysis, the 
ion trap MS was set to operate in a data-dependent 
mode with the Automatic Gain Control (AGC) on. 
The MS/MS data were first evaluated against several 
internal   quality control (QC) standards. After   passing 
the QC standards, the MS/MS data was loaded into 
the proprietary ProtQuest search engine to search the 
most  recent  non-  redundant  protein  database.  The 
results from the ProtQuest search were then manually 
analyzed.  The  endoproteinase  trypsin  (sequencing 
grade) was obtained from Promega or Roche (India-
napolis,  IN). The  ammonia  bicarbonate  (analytical 
grade) and HOAC (.99.8% purity) were obtained 
from  Sigma.  ACN,    methanol  (MeOH),  and  water 
were  each  HPLC  grade  and  obtained  from  Sigma 
(St. Louis, MO).
statistical analysis
The sensitivities and specificities of the ELISA test 
for  the  diagnoses  in  the  TB  and  Non-TB  groups 
were calculated. The positive and negative predictive 
values were calculated using different rates of TB 
prevalence. The receiver operating curve (ROC) was 
used to calculate the cut-off value, and comparisons 
between TB ascites and non-TB ascites groups were 
performed with the chi-square test.
Results
The  sample  populations  included  20  TB  ascites 
patients and 21 non-TB ascites patients. There were 
13 males and 7 females, with a mean age of 51.34 years 
(range 6 to 72 years) in TB ascites group. In the 
non-TB ascites control group, there were 11 males 
and  10  females,  with  a  mean  age  of  50.34  years 
(range 8 to 70 years). None of the patients were posi-
tive for anti-HIV antibodies, and none were receiv-
ing immunosuppressive drugs. None of the patients 
(except one case) experienced alternate constipation, 
diarrhea, weight loss or a doughy feeling on palpa-
tion of the abdomen.
To generate a ascitic fluid protein signature that 
was associated with the diagnosis of TB ascites, we 
first randomly selected a set of ten samples (five TB 
ascites positive and five negative patients) for two 
dimensional  electrophoresis.  Detailed  maps  of  the 
ascitic  fluid  proteins  of  TB  ascites  patients  were 
generated by 2 DGPE, A total of 285 protein spots 
were observed. Proteins that were up-regulated in TB 
ascites patients, compared to their levels in non-TB 
ascites patients, are shown in Figure 1. Eight proteins 
that were highly expressed in the TB ascites cases 
were selected for further molecular characterization 
using  LC-MS/MS.  These  eight  proteins  were  also 
selected in order to identify ascitic fluid protein sig-
nature specific for TB ascites.
One of the eight proteins was a 30 kDa protein that 
demonstrated a significant homology to the Antigen 85 
complex, another containing 65 and 71 kDa proteins 
that  correspond  to  amino  acid  sequences  of  MTB 
65-kDa HSP and 71-kDa HSP, respectively. Another 
was a 14-kDa protein that exhibited an amino acid 
sequence that was identical to that of the 14-kDa HSP 
(Table 1). Although amino acid sequences were also 
obtained for the four other selected proteins, none of 
these showed significant homology to the sequences 
of  any  known  protein.  These  results  were  recon-
firmed  through  immunoblot  analysis  with  specific 
PAbs against the identified proteins (14, 30, 65, 71). 
When 2D PAGE protein profile was probed with the Tuberculous ascites diagnosis
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  respective PAbs, the demonstrated reactivity was most 
strongly seen in the abdominal TB patients (Fig. 2).
After  the  identification  of  MTB  proteins  in  the 
ascitic fluid of TB ascites patients using the combined 
system of 2D PAGE, LC-MS/MS and Immunoblot 
analysis. ELISA was performed to evaluate the pro-
tein levels in the ascitic fluid samples of suspected TB 
ascites patients by using antibodies against each of the 
Non-TB ascites TB ascites
Figure 1. Two dimensional gel electrophoresis of the ‘ascitic fluid’ collected from A) TB ascites (n = 5) and B) non- TB ascites (n = 5) patients. Proteins 
which are up regulated in the TB ascites patients are indicated with  .
identified proteins that were obtained from   Colorado 
State University, USA.
The mean absorbance value of all the identified 
antigens  (14-kDa  HSP,  Ag  85  complex,  65-kDa 
HSP, 71-kDa HSP ) are shown in Tables 2–5. The 
antigen activity of all the antigens in the Tb ascites 
group is significantly higher than the non-TB ascites 
subjects.
Table  1.  MS  identification  of  the  protein(s)  bands  in  TB  ascites  patients.  The  peptides  were  detected  by  liquid 
  chromatography-tandem mass spectrometry (Lc-Ms/Ms) analysis.
protein peptide sequence Amino acid positiona % Totalb
14 kDa PeFse 16–20 3.47
FDgr seFAYgsFVr 87–100 9.72
% coverage 13.19
Ag 85 complex rrLMIgTA AA 13–22 3.07
PgLPVeY LQVP 43–53 3.3
eLPQWLs AnrAVKPTgs AAIgLsM 144–167 7.3
ALLDPsQgMg 
PsLIgLAMgD AggYKA
191–216 8
ThsWeYWgAQ LnA 301–313 4
% coverage 25.67
65 kDa eKIgA 5–9 2.4
VAAgA 45–49 2.4
AKeVeTKe 73–80 3.9
erQ 145–148 1.9
sTVKD  165–170 2.4
IIAeD 186–190 2.4
% coverage 15.4
70 kDa rhMgsDWsIe IDgKKY 71–86 2.56
PYITV DADKnPLFLD 256–270 2.4
rKrreeADVr nQAe 501–604 2.24
% coverage   7.2
notes: aAmino acid position of the peptide in the mature   protein; bPercentage the peptides contributes to the total mass of the mature protein.Kashyap et al
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Figure 2. Immunoblot analysis of the identified proteins, demonstrat-
ing reactivity with the polyclonal antibodies against A) Ag 85 complex 
B)  Mycobacterium  tuberculosis  heat  shock  protein  14  (14-kDa  hsP) 
c)  Mycobacterium  tuberculosis  heat  shock  protein  65  (65-kDa  hsP)   
D) Mycobacterium tuberculosis heat shock protein 71 (71-kDa hsP).
The identified diagnostic marker specific to TB 
ascites  showed  good  sensitivity  (72%–100%)  and 
specificity (76%–95%) when tested with clinical sam-
ples of TB ascites and non-TB ascites subjects.
Discussion
This  study,  to  the  best  of  our  knowledge,  is  the 
first detailed description of the protein profiles of a 
reasonably large panel of biomarkers, which were 
assessed  simultaneously  using  2  DPGE,  LC-MS/
MS  and  immunoblot  analyses  of  the  ascitic  fluid 
and were compared between TB ascites patients and 
non-TB ascites patients. Our results indicate that the 
identifying antigen(s) might be useful for the devel-
opment of diagnostic tool for the diagnosis of TB 
ascites.
First  antigen, Antigen  85  Complex  represents  a 
family  of  fibronectin-binding  proteins,  which  are 
most  prominently  represented  by  85A  and  85B. 
Members of this complex have been found to be both 
secreted and retained in the cell wall of MTB.10 These 
proteins have been found in the blood and sputum of 
pulmonary tuberculosis patients.11–13 We previously 
demonstrated the presence of an Antigen 85 complex 
in the tuberculous meningitis (TBM) and pulmonary 
tuberculosis patients.9,14,15
Another promising systemic marker identified in 
this study for tuberculosis ascites is the 14-kDa HSP 
(alpha crystallin family), Rv 3418c. It was originally 
identified by three MAbs that were generated in two 
separate laboratories16,17 and was previously assigned 
an apparent molecular weight of 16,000 Da.18 The 
14-kDa HSP antigen has previously shown consider-
able promise as a serodiagnostic target in assay pro-
tocols that were based upon MAb competition and by 
ELISA assay.19,20
The MTB 65-kDa HSP was identified as a another 
potential  ascitic  fluid  biomarker  for  TB  ascites. 
This protein is produced in response to host reac-
tion  during  infection,  which  is  the  reason  that  the 
more general term, stress protein, has been applied 
to this particular protein class.21 An earlier study in 
our laboratory appears to have been the first used of 
this antigen for the diagnosis of TBM and pulmonary 
tuberculosis.22,23
On the other hand, significant differences for the 
level of the 71-kDa HSP protein were also observed 
between TB ascites and controls. This particular anti-
gen from mycobacteria has been identified as a target 
of the humoral and cellular immune responses dur-
ing mycobacterial infection.24 In single study, using 
Immunohistochemical analysis Dubaniewicz A et al 
reported  the  expression  of  hsp70Mtb,  hsp65Mtb,  and 
hsp16Mtb in all 25 lymph node tissues and tuberculous 
granulomas from patients with sarcoidosis and in one 
non-specific lymphadenopathy case with only weak 
hsp70Mtb reactivity.25
In  conclusion,  we  hypothesize  that  the  65-kDa 
HSP, 71-kDa HSP, 14-kDa HSP and Ag 85 complex 
proteins may have an important role in the diagnosis 
of TB ascites. Additional studies that included a high 
number of ascitic fluid samples will be required in 
order to determine the sensitivity and specificity of 
these potential proteins as biomarkers for TB ascites. 
The identification of these markers can contribute to 
the clinical diagnosis of TB ascites and may also pro-
vide additional insight into the pathogenesis of TB 
ascites.
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Table 2. representation of Mycobacterium tuberculosis heat shock protein 14 (14-kDa HSP), in ascitic fluid from TB ascites 
and non-TB ascites patients using the antibodies generated against 14-kDa hsP by eLIsA.
patients 
group 
positive for 14 kDa  
Hsp antigen  
(cut off 0.631)
negative for 14 kDa  
Hsp antigen  
(cut off 0.631)
Absorbance 
(mean ± sD)
Range
TB ascites 
(n = 18)
18 (100%) 0 (00%) 0.814 ± 0.134 0.637–1.029
non TB ascites 
(n = 21)
5 (23.80%) 16 (76.20%) 0.571 ± 0.118 0.336–0.907
The mean 14-kDa HSP antigen value (with range) in the TB ascites group was significantly higher than that in the non-TB ascites group [p , 0.0001].
Table 3. Demonstration of the Antigen (Ag) 85 Complex antigens in ascitic fluid from TB ascites and non-TB ascites patients 
using the antibodies against the purified MTB B and C (Ag 85) complex, CS-90, received from Colorado State University, 
UsA by eLIsA. 
patients 
group
positive for  
antigen 85 complex  
(cut off 0.762)
negative for  
antigen 85 complex  
(cut off 0.762)
Absorbance 
(mean ± sD)
Range
TB ascites 
(n = 18)
13 (72.22%) 5 (27.78%) 0.824 ± 0.193 0.45–1.27
non TB ascites 
(n = 21)
2 (9.52%) 19 (90.48%) 0.593 ± 0.172 0.374–1.31
The mean Ag 85 complex value in the TB ascites group was higher than in the non-TB ascites group [p , 0.0001].
Table 4. Demonstration of the Mycobacterium tuberculosis heat shock protein 65 (65-kDa HSP), Rv0440; in ascitic fluid 
from TB ascites and non-TB ascites patients using the antibodies against the 65-kDa hsP, received from colorado state 
University, UsA by eLIsA.
patients 
group
positive for 65 kDa  
Hsp antigen  
(cut off 0.722)
negative for 65 kDa  
Hsp antigen  
(cut off 0.722)
Absorbance 
(mean ± sD)
Range
TB ascites 
(n = 18)
16 (88.88%) 2 (11.12%) 0.816 ± 0.129 0.453–0.975
non TB ascites 
(n = 21)
1 (4.76%) 20 (95.24%) 0.561 ± 0.113 0.39–1.01
The mean absorbance value of the 65-kDa HSP antigen in TB ascites patients was significantly higher than in the non-TB ascites group [p , 0.001].
Table 5. representation of Mycobacterium tuberculosis heat shock protein 71 (71-kDa HSP), Rv0350 in ascitic fluid from 
TB ascites and non-TB ascites patients using the antibodies generated against 71-kDa hsP by eLIsA.
patients 
group
positive for 71 kDa  
Hsp antigen  
(cut off 0.860)
negative for 71 kDa  
Hsp antigen  
(cut off 0.860)
Absorbance 
(mean ± sD)
Range
TB ascites 
(n = 18)
15 (83.33%) 3 (16.67%) 0.968 ± 0.261 0.481–1.615
non TB ascites 
(n = 21)
5 (23.80%) 16 (76.20%) 0.644 ± 0.198 0.362–1.136
The mean 71-kDa HSP antigen level in the TB ascites group was significantly higher than that in the non-TB ascites group [p = 0.0005].publish with Libertas Academica and 
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